Additionally, loss of FREM2 function is an important cause of blood-related kidneys (Al-Hamed et al., 2021), and FREM2 has been suggested to be a candidate prognostic marker in glioma (Vidak et al., 2018). The gene discussed is FREM2; the disease is glioma.